Skip to Main Content

Paper Details

Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis.
J Neurol Neurosurg Psychiatry
2
2023
Author NameAffiliation
James D BowenSwedish Neuroscience Institute
Gary CutterUniversity of Alabama at Birmingham
  • 1 - 2

Datasets

Release 1.2